Bengaluru, Jul 3 (PTI): Biocon founder Kiran Mazumdar-Shaw on Thursday opposed Karnataka Chief Minister Siddaramaiah's remarks linking covid-19 vaccines with a spate of heart attack deaths in the state's Hassan district, saying such claims are "'factually incorrect" and "misleading".
Siddaramaiah has suggested that the recent heart attack deaths in Hassan district may be linked to the vaccination drive. He had also claimed the vaccines were 'hastily' approved.
In a social media post, Shaw said "covid-19 vaccines developed in India were approved under the Emergency Use Authorisation framework, following rigorous protocols aligned with global standards for safety and efficacy. To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation."
"These vaccines have saved millions of lives and, like all vaccines, may cause side effects in a very small number of individuals. It is important to acknowledge the science and data-driven processes behind their development, rather than engage in retrospective blame," Shaw, Executive Chairperson of the pharma company, said.
The Chief Minister had said on Tuesday that over 20 people had died of heart attack in Hassan district in the past month alone, and that the state government was taking the matter seriously.
He announced the formation of an expert committee led by Dr Ravindranath, Director of Jayadeva Institute of Cardiovascular Sciences and Research, to investigate the deaths. The committee has been instructed to submit its report within ten days.
The CM said a similar directive had been issued in February to study sudden deaths among young people across the state and whether covid-19 vaccines could have had any adverse effects
"It cannot be denied that the hasty approval and distribution of the covid vaccine to the public could also be a reason for these deaths, as several studies worldwide have recently indicated that covid vaccines could be a cause for the increasing number of heart attacks," Siddaramaiah had said.
On Wednesday, the Union Health Ministry had dismissed the CM's statement, saying extensive studies by ICMR and AIIMS have conclusively established no linkages between coronavirus vaccines and sudden deaths.
Studies by the Indian Council of Medical Research (ICMR) and National Centre for Disease Control (NCDC) affirm that covid-19 vaccines in India are safe and effective, with extremely rare instances of serious side effects, it said.
Sudden cardiac deaths can result from a wide range of factors, including genetics, lifestyle, pre-existing conditions, and post-covid complications, the ministry had said in a statement.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Bengaluru: The state government on Monday rolled out a new excise policy that shifts from the decades-old bulk litre-based system to a model based on alcohol content in beverages, Deccan Herald reported.
Karnataka becomes the first state in India to adopt this model. The change is expected to make lower-priced liquor costlier, while some premium brands may see a reduction in prices.
A senior Excise Department official said: “The policy is being implemented from today (May 11). The Karnataka Excise (Excise Duty and Charges) (2nd Amendment) Rules, 2026, notified after a public consultation on a draft released on April 18, slashes the number of excise slabs from 16 to 8.”
Local liquor manufacturers have alleged that the policy favours multinational companies producing beer and spirits over domestic distilleries.
According to the Karnataka Brewers and Distillers Association (KBDA), the first five slabs, which cater to the common man, house the maximum number of state-owned distilleries and contribute nearly 70-75% of the state’s excise revenue, have seen their Additional Excise Duty (AED) rise by 20-30%.
In contrast, slabs 6 to 8, which include products from multinational companies such as United Spirits, Bacardi, Heineken, Carlsberg, and Anheuser-Busch, have seen AED reduced by 10-15%. The association said that while larger companies can absorb pricing shifts across their diverse portfolios, smaller regional distilleries limited to budget liquor may face volume contraction and potential closure.
A senior KBDA member said the price of a 180 ml bottle in the lowest slab, which was around Rs 63 last year, has already risen to Rs 80, and the new policy is set to push that price further to Rs 105 a jump driven by a 42.8% tax bracket.
